JPRN-UMIN000013364已完成未知
A prospective, single-center randomised double-blinded parallel-group comparison study of the postoperative pain control efficacy of a sciatic nerve block versus combined local anaesthetic infiltration and continuous femoral nerve block after total knee arthroplasty - Postoperative pain control efficacy of a sciatic nerve block versus combined local anaesthetic infiltration and continuous femoral nerve block after total knee arthroplasty
Saitama City Hospital0 个研究点目标入组 34 人开始时间: 2014年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Bilateral TKA Regular narcotic users Allergy to any study drug Neuromuscular disease Sensory disturbances of the leg Severe diabetes Heart failure (AHA >3) Renal impairment with an estimated glomerular filtration rate of <60 mL min-1 1.73 m-2, Liver dysfunction (Child–Pugh > B) Impossible to assess using the numeric rating scale (NRS)
研究者
相似试验
已完成
不适用
A prospective, single-centre, randomised, double-blind, placebo-controlled trial to assess the analgesic effects of one-week treatment with anti-tumour necrotising factor (TNF) in patients with lower back and leg paiISRCTN14943354Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)40
进行中（未招募）
1 期
A controlled clinical study to investigate the effectiveness and safety of the medicine called masitinib when used together with a currently available medicine Riluzole when treating the illness called Amyotrophic Lateral Sclerosis (ALS)Amyotrophic lateral SclerosisMedDRA version: 18.0Level: PTClassification code 10028003Term: Motor neurone diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.0Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-024423-24-IEAB Science381
进行中（未招募）
1 期
Evaluation of masitinib in Amyotrophic Lateral Sclerosis (ALS)patients suffering from Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-001862-13-NOABScience495
进行中（未招募）
1 期
Evaluation of masitinib in Amyotrophic Lateral Sclerosis (ALS)patients suffering from Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-001862-13-ESABScience495
撤回
3 期
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with Riluzole versus placebo in combination with Riluzole in the treatment of patients suffering from Amyotrophic Lateral Sclerosis (ALS)ALSamyotrophic lateral sclerosis10029317NL-OMON49977AB Science11